The U.S. Food and Drug Administrationexpanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenzafor patients 12 years of age and older after contact with an individual who has the flu. Xofluza, previously available only in[…]
Exposure to antibiotics before age 2 is associated with development of several health conditions including asthma, celiac disease, obesity and attention deficit hyperactivity in childhood, a new study found. The study, published in Mayo Clinic Proceedings, included 14,572 children born[…]
The Food and Drug Administration has approved a drug that extends the lives of children with an extremely rare genetic disorder that causes them to grow old before they grow up.The disorder, progeria, ages cells rapidly and prematurely.